The growth of the global diabetic shoes market size is being driven by the rising prevalence of the increasing diabetic patients across the globe. The market was estimated to be close to USD 7881.2 million in 2022. It is anticipated to grow at a CAGR of 8% during the forecast period of 2023-2031 to attain a value of USD 16051 million by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Diabetic shoes (also known as extra depth therapeutic shoes or sugar shoes) or shoe inserts are therapeutic footwear exclusively designed for diabetic patients. Diabetic patients have numerous other health issues as well. These patients could be suffering from obesity and other cardiovascular diseases. These therapeutic footwears help diabetic patients from the risk of skin disintegration in their feet. These shoes also help the patients with foot disease and also provide relief with foot pain and prevent diabetic foot ulcer.
Blood sugar levels that are higher than usual contribute to a lot of health problems in human body and one of them is poor blood circulation. This poor blood circulation can damage the nerves in the feet and can lead to the development of a condition called Neuropathy.
Neuropathy is a condition in which the patient complains about the lack of sensitivity in their feet. This insensitivity may cause some major issues for the people who are diabetics, that is, in any situation if they get hurt in their feet, be that a cut or anything that may cause the skin to get distorted, it may lead to a bigger issue. The untreated wounds may cause infections and poor blood circulation would make wounds or injuries take a longer time to heal than expected. This issue may sound just like any other minor health issue, but it has major impact on the life of diabetic patients.
Diabetic patients usually develop open sores on their feet, which hurt a lot and leave them in utter discomfort while wearing any regular shoes. These diabetic patients may also develop thick skinned areas of hardened skin tissues, and calluses on the bottom of their feet which also create discomfort. Mentioned below are the conditions that could develop in diabetic or non-diabetic patients and cause discomfort.
The global diabetic shoes market can be divided into segmentations like type, patient type, distribution channel, end users, and major regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Patient Type
Market Breakup by Distribution Channel
Diabetic Shoes Market by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is recording an evident rise in demand due to the high prevalence of increasing awareness among people, regarding their healthcare and diabetic or therapeutic footwear.
World Health Organization has estimated that around 27% diabetics are at acute risk of being exposed to the terminal neuropathy conditions. In United States, 28% of adults are at risk of these terminal neuropathies. People who are suffering from these neuropathies, about 50% of them have injured legs or feet. To save themselves from this harmful disease, people are now making these much useful choices. Using custom made therapeutic diabetic shoes, these patients can experience numerous benefits. Because these shoes are custom made to the specific concern of the patient, different material are used to manufacture them. These diabetic shoes reduce the risk of skin fallouts of diabetic patients.
The key players in the market are developing new trends so that more people get aware about their condition and start taking care of them. Following up with this trend, women are significantly contributing to the global diabetic shoes market. The shoes are also readily available in the market. These diabetic shoes are easily available at quite affordable prices, and in any nearby shoe outlets or even on online shops. The buyers of diabetic shoes do not have to suffer much to find these shoes, due to the easy availability in market. There are various manufacturers available in the market, who design and manufacture the diabetic shoes, just according to the specific requirements or concerns of the patient. Wearing diabetic shoes specific to the concern can be extremely helpful for the diabetic patient. These shoes come with soft inner soles and cushioning that helps proper support to the feet and provides comfort. These diabetic shoes provide maximum arch support and also minimize pressure on foot.
This report contains an in-depth analysis of all the leading key players in the global diabetic shoes market. The leading key players in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Patient Type||
|Breakup by Distribution Channel||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetes Overview
3.1 Guidelines and Stages
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetes Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Diabetes Epidemiology (2016-2031)
5.3 Europe Diabetes Epidemiology (2016-2031)
5.4 Asia Pacific Diabetes Epidemiology (2016-2031)
5.5 Latin America Diabetes Epidemiology (2016-2031)
5.6 Middle East and Africa Diabetes Epidemiology (2016-2031)
6 Global Diabetic Shoes Market Overview
6.1 Global Diabetic Shoes Market Historical Value (2016-2022)
6.2 Global Diabetic Shoes Market Forecast Value (2023-2031)
7 Global Diabetic Shoes Market Landscape
7.1 Diabetic Shoes: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Diabetic Shoes: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Patient Type
7.2.3 Analysis by Distribution Channel
7.2.4 Analysis by End User
8 Diabetic Shoes Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Diabetic Shoes Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Diabetic Shoes Market Segmentation
11.1 Global Diabetic Shoes Market by Type
11.1.1 Market Overview
11.1.2 Dress Shoes
11.1.3 Running Shoes
11.1.4 Strolling Shoes
11.2 Global Diabetic Shoes Market by Patient Type
11.2.1 Market Overview
11.3 Global Diabetic Shoes Market by Distribution Channel
11.3.1 Market Overview
188.8.131.52 Specialty Stores
184.108.40.206 Hypermarkets and Supermarkets
11.4 Global Diabetic Shoes Market by End User
11.4.1 Market Overview
11.5 Global Diabetic Shoes Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Diabetic Shoes Market
12.1 Market Share by Country
12.2 United States of America
13 Europe Diabetic Shoes Market
13.1 Market Share by Country
13.2 United Kingdom
14 Asia Pacific Diabetic Shoes Market
14.1 Market Share by Country
15 Latin America Diabetic Shoes Market
15.1 Market Share by Country
16 Middle East and Africa Diabetic Shoes Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.5 South Africa
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Aetrex Worldwide Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.2 Apis Footwear Company
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.3 Medical Expo
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.4 Dr Comfort
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.5 DARCO Medical India
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.6 DrewShoe Incorporated
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.7 Anodyne LLC
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.8 Podartis Srl
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.9 Orthofeet Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.10 Propet USA, Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
24 Diabetic Shoes - Distribution Model (Additional Insight)
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The global market attained a value of USD 7881.2 million in 2022.
The global market is expected to grow at a CAGR of 8% during the forecast period of 2023-2031 to attain a value of USD 16051 million by 2031.
Diabetic shoes are therapeutic footwear to help diabetic patients with the conditions that occurs in their feet due to diabetes.
The diabetic shoes are therapeutic in nature as they acquire properties that help in relaxation of diabetic feet and skin fallouts as well. As the leading manufacturers of global market are also following the trends to be fashionable and comfortable at the same time is why these shoes are in demand globally.
The major regions in the market include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The types include dress shoes, running shoes, and strolling shoes, among others.
The patient types include outpatient and inpatient.
The distribution channels in the market include online and offline. Offline channels include speciality stores, hypermarkets, and supermarkets.
The end-users can be divided into women, men, and children.
The leading key players in the market include Aetrex Worldwide Inc., Apis Footwear Company, Medical Expo, Dr Comfort, DARCO Medical India, DrewShoe Incorporated, Anodyne LLC, Podartis Srl, Orthofeet Inc., and Propet USA, Inc., among others.
Single User License
Five User License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.